MedPath

ACCORD HEALTHCARE SL

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

629

CIMA_AEMPS:546
EMA:83

Drug Approvals

Osvyrti

Authorization Status
Authorised
Approval Date
May 26, 2025
EMA

Jubereq

Authorization Status
Authorised
Approval Date
May 26, 2025
EMA

Trabectedin Accord

Authorization Status
Authorised
Approval Date
Apr 25, 2025
EMA

Eltrombopag Accord

Authorization Status
Authorised
Approval Date
Mar 28, 2025
EMA

Hetronifly

Authorization Status
Authorised
Approval Date
Feb 3, 2025
EMA

Hetronifly

Authorization Status
Authorised
Approval Date
Feb 3, 2025
EMA

Hetronifly

Authorization Status
Authorised
Approval Date
Feb 3, 2025
EMA

Imuldosa

Authorization Status
Authorised
Approval Date
Dec 12, 2024
EMA

Absimky

Authorization Status
Authorised
Approval Date
Dec 12, 2024
EMA

Axitinib Accord

Authorization Status
Authorised
Approval Date
Sep 19, 2024
EMA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.